Cargando…

Isolated Lupus-Associated Protein-Losing Enteropathy in a Resource-Limited Centre

Systemic lupus erythematosus (SLE) is a relatively common autoimmune disease with recently reported cases of lupus-associated protein-losing enteropathy (LUPLE) as an unusual manifestation. It is a well-recognized clinical entity predominantly affecting middle-aged Asian females. LUPLE is diagnosed...

Descripción completa

Detalles Bibliográficos
Autores principales: Prabasara, Kasun, Sundaresan, K T, Rosa, Chamith
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301274/
https://www.ncbi.nlm.nih.gov/pubmed/34327069
http://dx.doi.org/10.7759/cureus.15826
_version_ 1783726630348259328
author Prabasara, Kasun
Sundaresan, K T
Rosa, Chamith
author_facet Prabasara, Kasun
Sundaresan, K T
Rosa, Chamith
author_sort Prabasara, Kasun
collection PubMed
description Systemic lupus erythematosus (SLE) is a relatively common autoimmune disease with recently reported cases of lupus-associated protein-losing enteropathy (LUPLE) as an unusual manifestation. It is a well-recognized clinical entity predominantly affecting middle-aged Asian females. LUPLE is diagnosed by exclusion of possible causes for hypoalbuminemia in a patient with positive anti-nuclear antibody (ANA). LUPLE as the first manifestation of SLE is rare but it is a well-recognized complication secondary to SLE. We report a case of a 39-year-old Sri Lankan lady who was investigated for generalized body swelling, pleural effusions, ascites and pericardial effusions due to hypoalbuminemia. Her ANA was positive with speckled pattern and intestinal biopsy samples revealed evidences of chronic inflammatory cell infiltrates in laminapropria. Her investigations were not suggestive of liver diseases, albuminuria or malnutrition. We excluded all possible etiologies for protein-losing enteropathy although gold standard tests to confirm it was not available in our center. In conclusion, LUPLE should be considered as an etiology for all the unexplained protein-losing enteropathies. We suggest to treat LUPLE with prednisolone, hydroxychloroquine (HCQ) followed by steroid-sparing agents such as azathioprine. Prognosis was excellent following appropriate treatment.
format Online
Article
Text
id pubmed-8301274
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-83012742021-07-28 Isolated Lupus-Associated Protein-Losing Enteropathy in a Resource-Limited Centre Prabasara, Kasun Sundaresan, K T Rosa, Chamith Cureus Rheumatology Systemic lupus erythematosus (SLE) is a relatively common autoimmune disease with recently reported cases of lupus-associated protein-losing enteropathy (LUPLE) as an unusual manifestation. It is a well-recognized clinical entity predominantly affecting middle-aged Asian females. LUPLE is diagnosed by exclusion of possible causes for hypoalbuminemia in a patient with positive anti-nuclear antibody (ANA). LUPLE as the first manifestation of SLE is rare but it is a well-recognized complication secondary to SLE. We report a case of a 39-year-old Sri Lankan lady who was investigated for generalized body swelling, pleural effusions, ascites and pericardial effusions due to hypoalbuminemia. Her ANA was positive with speckled pattern and intestinal biopsy samples revealed evidences of chronic inflammatory cell infiltrates in laminapropria. Her investigations were not suggestive of liver diseases, albuminuria or malnutrition. We excluded all possible etiologies for protein-losing enteropathy although gold standard tests to confirm it was not available in our center. In conclusion, LUPLE should be considered as an etiology for all the unexplained protein-losing enteropathies. We suggest to treat LUPLE with prednisolone, hydroxychloroquine (HCQ) followed by steroid-sparing agents such as azathioprine. Prognosis was excellent following appropriate treatment. Cureus 2021-06-22 /pmc/articles/PMC8301274/ /pubmed/34327069 http://dx.doi.org/10.7759/cureus.15826 Text en Copyright © 2021, Prabasara et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Rheumatology
Prabasara, Kasun
Sundaresan, K T
Rosa, Chamith
Isolated Lupus-Associated Protein-Losing Enteropathy in a Resource-Limited Centre
title Isolated Lupus-Associated Protein-Losing Enteropathy in a Resource-Limited Centre
title_full Isolated Lupus-Associated Protein-Losing Enteropathy in a Resource-Limited Centre
title_fullStr Isolated Lupus-Associated Protein-Losing Enteropathy in a Resource-Limited Centre
title_full_unstemmed Isolated Lupus-Associated Protein-Losing Enteropathy in a Resource-Limited Centre
title_short Isolated Lupus-Associated Protein-Losing Enteropathy in a Resource-Limited Centre
title_sort isolated lupus-associated protein-losing enteropathy in a resource-limited centre
topic Rheumatology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301274/
https://www.ncbi.nlm.nih.gov/pubmed/34327069
http://dx.doi.org/10.7759/cureus.15826
work_keys_str_mv AT prabasarakasun isolatedlupusassociatedproteinlosingenteropathyinaresourcelimitedcentre
AT sundaresankt isolatedlupusassociatedproteinlosingenteropathyinaresourcelimitedcentre
AT rosachamith isolatedlupusassociatedproteinlosingenteropathyinaresourcelimitedcentre